Home › Reference

Biblio

Export 1963 results:
Sort by: Author Title Type [ Year (Desc)]
2005
Ramasamy, S, Fry BG, Hodgson WC.  2005.  Neurotoxic effects of venoms from seven species of australasian black snakes (Pseudechis): Efficacy of black and tiger snake antivenoms.. Clin. Exp. Pharmacol. Physiol.. 32(1-2):7-12.
Lumsden, NG, Fry BG, Ventura S, Kini RM, Hodgson WC.  2005.  Pharmacological characterisation of a neurotoxin from the venom of Boiga dendrophila (Mangrove catsnake).. Toxicon. 45(3):329-334.
Kuruppu, S, Fry BG, Hodgson WC.  2005.  Presynaptic neuromuscular activity of venom from the brown-headed snake (Glyphodon tristis).. Toxicon. 45(3):383-388.
Li, M, Fry BG, Kini RM.  2005.  Putting the brakes on snake venom evolution: The unique molecular evolutionary patterns of Aipysuras eydouxii (Marbled sea snake) phospholipase A2 toxins. Mol. Biol. Evol. 22(4):934-941.
Westhoff, G, Fry BG, Bleckmann H.  2005.  Sea snakes (Lapemis curtus) are sensitive to low-amplitude water motions.. Zoology (Jena). 108(3):195-200.
Wüster, W, Dumbrell AJ, Hay C, Pook CE, Williams DJ, Fry BG.  2005.  Snakes across the Strait: trans-Torresian phylogeographic relationships in three genera of Australasian snakes (Serpentes : Elapidae : Acanthophis, Oxyuranus, and Pseudechis).. Mol. Phylo. Evol. 34(1):1-14. Download: wuesteretal2005.pdf (343.52 KB)
Rogers, IR, Winkel KD.  2005.  Struan Sutherland's "Rationalisation of first-aid measures for elapid snakebite" - a commentary.. Wilderness Environ. Med.. 16(3):160-163.
2004
Lumsden, NG, Fry BG, Kini RM, Hodgson WC.  2004.  In vitro neuromuscular activity of 'colubrid' venoms: clinical and evolutionary implications. Toxicon. 43(7):819-827.
Cheng, AC, Winkel KD.  2004.  Antivenom efficacy, safety and availability: measuring smoke. Med. J. Aust.. 180(1):5-6.
Fry, BG, Wüster W.  2004.  Assembling an arsenal: Origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences.. Mol. Biol. Evol. 21(5):870-883.
Chetty, N, Du A, Hodgson WC, Winkel K, Fry BG.  2004.  The In Vitro Neuromuscular Activity of Indo-Pacific Sea-Snake Venoms: Efficacy of Two Commercially Available Antivenoms. Toxicon. 44(2):193-200.
Wickramaratna, JC, Fry BG, Loiacono RE, Aguilar M-I, Alewood PF, Hodgson WC.  2004.  Isolation and Characterisation at Cholinergic Nicotinic Receptors of a Neurotoxin from Venom of the Acanthophis Sp. Seram Death Adder. Biochemical Pharmacology. 68(2):383-394.
Hogan, CJ, Barbaro KC, Winkel K.  2004.  Loxoscelism: Old obstacles, new directions. Ann. Emerg. Med. 44(6):608-624.
Nevalainen, TJ, Peuravuori HJ, Quinn RJ, Llewellyn LE, Benzie JAH, Fenner PJ, Winkel KD.  2004.  Phospholipase A2 in Cnidaria. Comp. Biochem. & Physiol. B: Biochem. & Mol. Biol. 139(4):731-735.
McGain, F, Limbo A, Williams DJ, Didei G, Winkel KD.  2004.  Snakebite mortality at Port Moresby General Hospital, Papua New Guinea, 1992-2001. Med. J. Aust. 181(11-12):687-691.
Nimorakiotakis, B, Winkel KD.  2004.  The Funnel Web Spider and Common Spider Bites. Australian Family Physician. 33:244-251.
Nimorakiotakis, B, Winkel KD.  2004.  Spider Bite - The Redback Spider and Its Relatives. Australian Family Physician. 33:153-157.
2003
Fry, BG, Wüster W, Ramjan SFR, Jackson T, Martelli P, Kini RM.  2003.  Analysis of Colubroidea snake venoms by liquid chromatography with mass spectrometry: evolutionary and toxinological implications.. Rapid Comm. Mass Spect. 17(18):2047-2062.
Tibballs, J, Kuruppu S, Hodgson WC, Carroll T, Hawdon G, Sourial M, Baker T, Winkel K.  2003.  Cardiovascular, haematological and neurological effects of the venom of the Papua New Guinean small-eyed snake (Micropechis ikaheka) and their neutralisation with CSL polyvalent and black snake antivenoms. Toxicon. 42(6):647-655.
Hodgson, WC, Eriksson CO, Alewood PF, Fry BG.  2003.  Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): Efficacy of tiger snake antivenom.. Clin. Exp. Pharmacol. Physiol. 30(3):127-132.
Fry, BG, Winkel DK, Wickramaratna JC, Hodgson W, Wuster W.  2003.  Effectiveness of Snake Antivenom: Species and Regional Venom Variation and Its Clinical Impact. Journal of Toxicology. 22(1):23-24.
Wickramaratna, JC, Fry BG, Aguilar MI, Kini RM, Hodgson WC.  2003.  Isolation and pharmacological characterisation of a phospholipase A2 myotoxin from the venom of the Irian Jayan death adder (Acanthophis rugosus). Brit. J. Pharmacol.. 138(2):333-342.
Fry, BG, Lumsden NG, Wüster W, Wickramaratna JC, Hodgson WC, Kini RM.  2003.  Isolation of a neurotoxin (alpha colubritoxin) from a nonvenomous colubrid: Evidence for early origin of venom in snakes. J. Mol. Evol. 57(4):446-452.
Winkel, KD, Hawdon GM, Fenner PJ, Gershwin L, Collins AG, Tibballs J.  2003.  Jellyfish Antivenoms: Past, Present, and Future. Journal of Toxicology. 22(1):115-127.
Fry, BG, Wüster W, Kini RM, Brusic V, Khan A, Venkataraman D, Rooney AP.  2003.  Molecular evolution and phylogeny of elapid snake venom three-finger toxins.. J. Mol. Evol. 57(1):110-129.